These two medications, although similar in function, differ significantly in their mechanism of action and dosing protocols , which may affect how the body responds to treatment
West said the body naturally pushes back against weight loss by increasing hunger and lowering calorie burn
Lancet Diabetes Endocrinol 5(4):251260 Aroda VR, Bain SC, Cariou B, Pileti M, Rose L, Axelsen M, Rowe E, DeVries JH (2017) Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
While some studies have reported mixed findings, the strongest evidence does not support a clear link, and many reported associations are likely influenced by other lifestyle factors
In Irelands current healthcare environment, the safest path is: Clinical assessment Evidence-based treatment Ongoing monitoring Retatrutide represents the future, but regulated therapies represent the present